Chandra Bhagat Pharma Limited
Fixed Price Issue IPO · BSE
- Price band
- ₹51 - ₹51
- Lot size
- 2,000 shares
- Issue amount
- ₹10.2 cr
- Total subscription
- 0×
- Opens
- 31 Jan 2020
- Closes
- 6 Feb 2020
- Allotment
- 12 Feb 2020
- Listing
- 14 Feb 2020
Offer at a glance
Issue overview
- Issue size
- 20,00,000 shares
- Face value
- ₹10 Per Equity Share
- Minimum investment
- ₹1,02,000
- Fresh issue
- ₹0 cr
- Offer for sale
- ₹0 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- BSE
- Maximum investment
- ₹1,02,000
- Issue type
- Fixed Price Issue IPO
- Shares before issue
- 55,45,056
- Shares after issue
- 75,45,056
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 2,000 | ₹1,02,000 |
| HNI | 2 | 4,000 | ₹2,04,000 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
in Lakhs · Reported periods may include interim results.
Company information
Company profile
Chandra Bhagat Pharma Limited, established in 2003, is engaged in marketing lifesaving medicines in India across therapeutic areas such as cardiovascular care, cancer treatment, antibiotics, hormones, anesthesia, pediatrics, nephrology, antiviral, antifungal, and neurology. The company operates under its own brand with the support of an in-house sales team and distribution network that supplies healthcare centers and hospitals, while also dealing in specialty chemicals. In addition to finished formulations, it imports, supplies, and undertakes indenting of active pharmaceutical ingredients and intermediates, and holds FDA approval to manufacture formulations through contract manufacturers. Its storage facilities are located on a leased basis in Bhiwandi, Thane, Maharashtra, and the company also exports pharmaceutical products to international markets including DR Congo, Bolivia, and the Philippines.
Strengths
- Business model focused on customer needs and orders
- Strong ties with multinational companies (MNCs)
- Offers a wide range of products, including APIs and pharmaceuticals
- Has contract manufacturing services
- Operates in both Indian and global markets
Promoters
Mr. Hemant Chandravadan Bhagat,
Mr. Pranav Hemant Bhagat
Registrar & documents
Lead manager
Beeline Capital Advisors Private Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
323-F Bhagat Bhuvan, Dr. Ambedkar Road, Matunga (East) Mumbai- 400019
+91 22 2414 6154
[email protected]Company website ↗Understanding CBPL IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.